Christopher T. Giordano
2023
In 2023, Christopher T. Giordano earned a total compensation of $644.8K as President and Chief Executive Officer at Tenax Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,650 |
|---|---|
| Salary | $405,300 |
| Other | $36,820 |
| Total | $644,770 |
Giordano received $405.3K in salary, accounting for 63% of the total pay in 2023.
Giordano also received $202.7K in non-equity incentive plan and $36.8K in other compensation.
Rankings
In 2023, Christopher T. Giordano's compensation ranked 1,737th out of 3,006 executives tracked by ExecPay. In other words, Giordano earned more than 42.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,737 out of 3,006 | 42nd |
Division Manufacturing | 1,015 out of 1,650 | 39th |
Major group Chemicals And Allied Products | 644 out of 918 | 30th |
Industry group Drugs | 628 out of 881 | 29th |
Industry Pharmaceutical Preparations | 450 out of 637 | 29th |
Source: SEC filing on September 27, 2024.
Giordano's colleagues
We found two more compensation records of executives who worked with Christopher T. Giordano at Tenax Therapeutics in 2023.